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A B S T R A C T
38-year-old man had chronic deep venous thrombosis (DVT) as a result of multiple injuries caused by an explosion of
grenade 12 years ago, with recurrent pulmonary thromboembolisms and pulmonary hypertension which was unrecog-
nized for a decade. Patient was admitted with a progressive dyspnea and exercise intolerance (NYHA II). The diagnosis
was established according to clinical symptoms, transthoracic echocardiography, phlebography, lung scintigraphy and
pulmonary angiography. Oral anticoagulant therapy was introduced and cava filter indicated to implant. During phle-
bography a floating thrombus was found in the inferior cava vein underneath renal vein. Implantation was delayed and
patient received systemic fibrinolytic therapy with streptokinase (7 500 000 UI within 4 days), followed by heparin infu-
sion and warfarin. Post-fibrinolytic phlebography showed clear lumen of inferior vena cava. Fibrinolysis had also af-
fected pulmonary hypertension-systolic pressure in the right ventricle measured by Doppler echocardiography decreased
from 90 to 65 mmHg. Permanent intravenous cava filter was implanted.
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Introduction
Most patients with chronic thromboembolic pulmo-
nary hypertension present late in the course of the dis-
ease, remaining asymptomatic for months or years. The
pathophysiological events in the progression of pulmo-
nary hypertension during this period have not been well
defined1.
We report an successful use of high dose fibrinolytic
therapy with streptokinase infusion (Streptase, Hoechest
Marion Roussel) in resolving a newly-formed thrombus
in vena cava and reducing right ventricle pressure. The
role of fibrinolytic therapy with streptokinase in treating
pulmonary embolism was studied in different clinical tri-
als and published2,3,4.
According to our knowledge, in medical literature
there is no data about effects of streptokinase on pulmo-
nary hypertension caused by chronic thromboembolism.
We also present the result of molecular DNA diagnos-
tic method (real time PCR). It confirmed that patient is
homozygous for methylen – tetrahydrolate – reductase
mutation of high thromboembolic incidence, what is one
of risk factors for his clinical state.
Case Report
A 38-year-old man was injured in the right shin bone
by rifle-grenade explosion twelve years ago. Taking into
account his sedentary life style and office work, he did
not have any specific symptoms which could direct atten-
tion to his condition for years. The overload of the right
heart was noticed on ECG by general practicioner ten
years later. It was interpreted as pulmonary hyperten-
sion and suspected atrial septal defect (ASD). Echo-
cardiography showed elevated pressure in the right ven-
tricle (90 mm Hg), but ASD was not found. The first
admission to our Department was 8 months ago with
symptoms of progressive dyspnea and exercise intoler-
ance worsening within last six months (NYHA class II).
On physical examination pulmonic component of the sec-
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ond heart sound (P2) was loud, demonstrating fixed
splitting. Systolic ejection murmur was heard over aortic
and pulmonic area without propagation. On his right
shin bone there were multiple old injuries and varicose
veins. The measured circumference of right shin bone
was 4 cm greater than the left one. On transtoracic
echocardiography, enlargement of right ventricle showed
pulmonary hypertension and Doppler scaning of lower
extremities showed normal venous perfusion. Suspecting
deep venous thrombosis (DVT), despite negative Doppler
results, other diagnostic methods were done to confirm
it. Venography of the lower extremities showed multiple
thrombi in the right distal extremity veins, obstructing
the perfusion in tibial anterior veins, fibular veins, right
popliteal and femoral vein together with right external
iliac and common iliac vein. The collateral circulation
was developed. Chest computed tomographic scaning
(CT) showed asymemetric wall thickening along the lat-
eral aspect of pulmonary artery truncus narrowing its
distal branches. Radioisotopic ventilation-perfusion sca-
nning presented mismatched, segmental defects, left api-
cal, posterior and anterior lobus. Transfemoral right-
-heart catheterization measured pulmonary artery pres-
sure of 55/9 mm Hg and tested reversibility of hyperten-
sion with intravenously prostacyclin was negative. Pul-
monary angiography showed intraluminal filling defect
of main left pulmonary artery for apical lobus (Figure 1).
Molecular diagnostic method (real time PCR) for DNA
analyses identified MTHFR 677 TT genotype and sho-
wed that patient is homozygous for mutation as one of
risk factors for his clinical state. Homocystein level was
25,61 mmol/L (normal range 5–15 mmol/L) Vitamin B12
and folic acid supplementation was introduce in therapy.
Warfarin therapy was introduced and controlled by
PT and INR. We took into consideration implantation of
a cava filter to prevent further thromboembolisms. After
two months of anticoagulant therapy, cavography was
performed due to positioning of cava filter. Surprisingly,
a new floating thrombus was found 3 cm caudally from
the distal renal vein (Figure 2). We receded from cava fil-
ter placement and introduced intravenous fibrinolytic
therapy with 7 500 000 UI of streptokinase through 4
days, continued with unfractionated heparin for a week.
Then, we performed ultrasonography and phlebography
which showed clear lumen of inferior vena cava. On
transthoracic echocardiography, right ventricle pressure
was reduced from 90 mmHg to 65 mmHg. Homocystein
level after supplementation vitamin B12 and folic acid
therapy was in the normal range, 14,2 mmol/L. Patient
clinical state improved in functional class to NYHA I.
Finally, permanent cava filter was implanted (Figure 3).
The patient was dismissed and continued to receive life-
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Fig. 1. Pulmonary angiography – intrluminal filling defect of
main left pulmonary artery.
Fig. 2. Cavography – floating thrombus in inferior vena cava.
Fig. 3. Inferior vena cava phlebography after fibrinolytic therapy
with cava filter.
long anticoagulant therapy and vitamin B12 and folic
acid supplementation therapy.
Discussion
In this paper, we report a case of a patient with pul-
monary hypertension as a result of chronic thrombo-
embolism in whome fibrinolytic therapy was considered
to resolve inferior vena cava thrombus, before perma-
nent vena cava filter implantation. Additionally, after the
therapy right ventricle pressure was 65 mmHg vs. 90
mmHg before fibrinolysis and patient condition impro-
ved. In the literature, there are data on successful using
of fibrinolytic treatment of pulmonary thromboembo-
lism5,6. According to our results, the pressure in the right
ventricle showed significant decrease after fibrinolytic
therapy (D 25 mmHg), comparing to a study by Jerjes-
-Sanchez et al.2 where pulmonary artery pressure post-
-thrombolysis was 23 mmHg and pre-thrombolysis was
38 mm Hg (D 15 mmHg).
Real time PCR as method of DNA analyses identified
MTHFR 677 TT genotype (enzym MTHFR is responsible
for regeneration of metionin from homocystein). Enzy-
matic mutation (677 TT) increases concentration of se-
rum homocystein and has significance in evolution of
atheroslerosis, cardiovascular disease, dementia, hyper-
homocysteinemia7. Important concept is that patient is
homozygous for mutation of clinical risk for thromboem-
bolic incidecences.
We concluded that fibrinolytic therapy was, in our
case, primary therapeutic option for inferior vena cava
thrombosis, but additionally, it improved patient’s clini-
cal condition and severity of pulmonary hypertension es-
timated by echocardiography.
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PLU]NA HIPERTENZIJA U BOLESNIKA S POVI[ENIM HOMOCISTEINOM I OZLJEDAMA NAKON
EKSPLOZIJE GRANATE
S A @ E T A K
Bolesnik, star 38 godina sa kroni~nom dubokom venskom trombozom kao posljedicom povi{ene razine homocisteina
i brojnih ozljeda potkoljenic kao posljedica eksplozije granate prije 12 godina, te ponovljaju}im plu}nim embolijama i
plu}nom hipertenzijom koji nisu bili prepoznati ~itavo desetlje}e. Bolesnik je primljen putem hitne slu`be zbog pro-
gresivne zaduhe i intolerancije napora. Dijagnoza je postavljena temeljem ehokardiografije, flebografije, scintigrafije
plu}a i plu}ne angiografije. Tijekom flebografije na|en je flotiraju}i tromb u donjoj {upljoj veni te je bolesnik dobio
fibrinoliti~ku treapiju streptokinazom (7 500 000 IU kroz 4 dana), te potom kontinuirani heparin i warfarin. Post –
fibrinoliti~ka flebografija pokazala je uredan lumen donje {uplje vene. Fibrinoliza je tako|er utjecala na smanjenje
tlaka u plu}noj arteriji sa 90 na 65 mmHg. Kona~no, ugra|en je trajni filter u donju {uplju venu.
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